Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients

Anne-Claire Voegeli; Anne-Elisabeth Quoix; Bertrand Mennecier; Christine M. Maugard; Dominique Guenot; Eric Guerin; Michele Beau-Faller; Michele Legrain; Nathalie Prim; Noelle Weingertner

首页> 外文期刊>European respiratory review >Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients

【24h】

Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients

机译：非小细胞肺癌患者生殖系外显子21 EGFR突变V843I和P848L

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European respiratory review》 |2014年第133期|共页
作者
Anne-Claire Voegeli; Anne-Elisabeth Quoix; Bertrand Mennecier; Christine M. Maugard; Dominique Guenot; Eric Guerin; Michele Beau-Faller; Michele Legrain; Nathalie Prim; Noelle Weingertner;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类呼吸系及胸部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. A dramatic lung cancer course in a patient with a rare EGFR germline mutation exon 21 V843I: Is EGFR TKI resistance predictable? [J] . DemierreN., ZoeteV., MichielinO., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2013,第1期

机译：EGFR生殖系突变罕见的外显子21 V843I：一个显着的肺癌病程：EGFR TKI耐药性可预测吗？
2. Better survival with EGFR exon 19 than exon 21 mutations in gefitinib-treated non-small cell lung cancer patients is due to differential inhibition of downstream signals. [J] . Zhu JQ, Zhong WZ, Zhang GC, Cancer letters . 2008,第2期

机译：在吉非替尼治疗的非小细胞肺癌患者中，EGFR外显子19的存活率比外显子21突变的存活率更高，这是由于下游信号的差异性抑制所致。
3. EGFR-tyrosine kinase inhibitor treatment in a patient with advanced non-small cell lung cancer and concurrent exon 19 and 21 EGFR mutations: A case report and review of the literature [J] . Yang Yang, Zhang Biao, Li Rutian, Oncology letters . 2016,第5aPta2期

机译：EGFR-酪氨酸激酶抑制剂治疗晚期非小细胞肺癌并发外显子19和21 EGFR突变的患者：病例报告和文献复习
4. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
5. Design, Construction, and Verification of a LATE-PCR and Lights-On/Lights-Off Probe Assay for Mutation Detection in Exons 18-21 of the EGFR Gene: Implications for Molecular Diagnosis of Non-Small Cell Lung Carcinoma [D] . Tetrault, Shana Augustin 2012

机译：用于EGFR基因外显子18-21突变检测的LATE-PCR和开/关灯探针检测的设计，构建和验证：对非小细胞肺癌的分子诊断意义
6. Association between EGFR exon 19 or exon 21 mutations and survival rates after first-line EGFR-TKI treatment in patients with non-small cell lung cancer [O] . Haiying Jiang, Mei Zhu, Yanfang Li, -1

机译：非小细胞肺癌一线EGFR-TKI治疗后EGFR外显子19或21外显子突变与生存率的关系
7. Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients [O] . Nathalie Prim, Michele Legrain, Eric Guerin, 2014

机译：生殖细胞外显子21 EGFR突变，V843I和p848L，在非小细胞肺癌患者中

Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients

著录项

相似文献

相关主题

期刊订阅